NextGen Healthcare, Inc.
NXGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $176 | $178 | $179 | $162 |
| % Growth | -1% | -0.2% | 10.3% | – |
| Cost of Goods Sold | $95 | $98 | $94 | $85 |
| Gross Profit | $82 | $80 | $85 | $77 |
| % Margin | 46.3% | 44.8% | 47.3% | 47.3% |
| R&D Expenses | $18 | $21 | $20 | $20 |
| G&A Expenses | $0 | $0 | $73 | $0 |
| SG&A Expenses | $54 | $48 | $83 | $46 |
| Sales & Mktg Exp. | $0 | $0 | $10 | $0 |
| Other Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Expenses | $73 | $70 | $105 | $67 |
| Operating Income | $8 | $12 | -$20 | $10 |
| % Margin | 4.6% | 6.9% | -11.3% | 5.9% |
| Other Income/Exp. Net | -$1 | -$1 | -$5 | -$1 |
| Pre-Tax Income | $7 | $9 | -$25 | $9 |
| Tax Expense | $2 | $2 | $0 | $1 |
| Net Income | $5 | $6 | -$25 | $8 |
| % Margin | 2.9% | 3.5% | -14.1% | 4.8% |
| EPS | 0.08 | 0.09 | -0.38 | 0.12 |
| % Growth | -11.1% | 123.7% | -416.7% | – |
| EPS Diluted | 0.07 | 0.09 | -0.38 | 0.12 |
| Weighted Avg Shares Out | 67 | 66 | 66 | 67 |
| Weighted Avg Shares Out Dil | 68 | 67 | 66 | 67 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $2 |
| Interest Expense | $3 | $3 | $3 | $2 |
| Depreciation & Amortization | $9 | $9 | $12 | $11 |
| EBITDA | $19 | $22 | -$8 | $20 |
| % Margin | 11% | 12.1% | -4.3% | 12.5% |